Referencias Bibliográficas:
1. Baslow, MH. Function of the N-acetyl-L-histidine system in the vertebrate eye. Evidence in support of a role as a molecular water pump. J Mol Neurosci,1998,10(3),193-208.
2. Jackson, MC, Lenney, JF. The distribution of carnosine and related dipeptides in rat and human tissues. Inflamm Res 1996,45(3):132-5.
3. Gariballa, SE, Sinclair, Al. Carnosine: physiological properties and therapeutic potential. Age and Aging, 2000,29:207-210.
4. Quinn PL Baldyrev AA. Formaziuk VH. Carnosine: its properties, functions and potential therapeutic applications. Mol Aspects Mod,1992,13(5):379-444.
5. Stuerenburg HJ, Kunze K; Concentrations of free carnosine (a putative membrane-protective antioxidant) in human muscle Biopsies and rat muscles. Archives of Gerontology and Geriatrics,1999, 29: 107-113. 6. Hipkiss, AR, Brownson, C. A possible new role for the anti-aging peptide carnosine. Cell Mol Life Sci, 2000, 57 (5): 747-53.
7. Hipkiss, AR, Preston, JE, Himsworth, DT, Worthington, VC, Keown, M, Michaelis, J, Lawrence, J, Mateen, A, Allende, L, Eagles, PA, Abbott, NI. Pluripotent protective effects of carnosine, a naturally occuring dipeptide. Ann N Y Acad Sci,1998, 854:37-53.
8. Hipkiss AR. Carnosine, a protective, anti-aging peptide? Int J biochem Cell Bio1,1998, 30(8): 863-8. 9. Yuneva, M.O., Bulygina, E.R., Gallant, S.C., et al. Effect of carnosine on age-induced changes in senescence-accelerated mice. J Anti-Aging Medicine, 2: 1999, 337-342.
10. McFarland, GA, Holliday, R. Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res, 1994, 212(2): 167-75.
11. Dunnett M., Harris R.C. "influence of oral beta-alanine and L-histidine supplementation on the carnosine content of the gluteus medius". Equine Vet. J. Suppl. 1999;30:499-504.
12. Dunnet M, Harris Rc, Dunnet C.E., Harris P.A. "Plasma carnosine concentration: diurnal variation and effects of age, exercise and muscle damage". Equine Vet. J. Suppl. 2002 (34):283-7.
13. Trombley PQ, Horning MS, Blakemore LJ. Interactions between carnosine and zinc and copper: implications for neuromodulation and neuroprotection. Biochemistry (Mosc). 2000 Ju1;65(7):807-16. Review
14. Horning MS, Blakemore LJ, Trombley PQ. Endogenous mechanisms of neuroprotection: role of zinc, copper, and carnosine. Brain Res.
15. Coddou C, Morales B, Huidobro-Toro JP. Neuromodulator role of zinc and copper during prolonged ATP applications to P2X4 purinoceptors
16. Dukic-Stefanovic S, Schinzel R, Riederer P, Munch G. AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
17. Bonfanti L, Peretto P, De Marchis S et al. Carnosine-related dipeptides in the mammalian brain. Prog Neurobiol. 1999 Nov;59(4):333-53. Review.
18. Hipkiss AR. et al. Protective effects of carnosine against MDA-induced toxicity towards cultured rat brain endothelial cells. Neuroscience Letters. 1997. 135-138.
19. Rubtsov AM. Molecular mechanisms of regulation of the activity of sarcoplasmic reticulum Ca-release channels (ryanodine receptors), muscle fatigue, and Severin's phenomenon. Biochemistry (Mosc). 2001 Oct;66(10):1132-43.
20. Chez MG, Buchanan CP, Aimonovitch MC, Becker M, Schaefer K, Black C, Komen J. Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child. Neurol. 2002 Nov;17(11):833-7.
21. Damon BM, Hsu AC, Stark HJ, Dawson MJ. The carnosine C-2 proton's chemical shift reports intracellular pH in oxidative and glycolytic muscle fibers. Magn Reson Med. 2003 Feb;49(2):233-40. 22. Aldini G, Carini M, Beretta G, et al. Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction? Biochem Biophys Res Commun. 2002a;298(5):699-706.
23. Aldini G, Granata P, Carini M. Detoxification of cytotoxic alpha,beta-unsaturated aldehydes by carnosine: characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography/mass spectrometry in rat skeletal muscle. J Mass Spectrom. 2002b Dec;37(12):1219-28.
24. Suzuki Y, Ito O, Mukai N, Takahashi H, Takamatsu K. High Level of Skeletal Muscle Carnosine Contributes to the Latter Half of Exercise Performance during 30-s Maximal Cycle Ergometer Sprinting. Jpn J Physiol. 2002;52(2):199-205
25. Nagasawa T, Yonekura T, Nishizawa N, Kitts DI). In vitro and in vivo inhibition of muscle lipid and protein oxidation by carnosine. Mol Cell Biochem. 2001;225(1-):29-34.
26. Decker EA, Livisay SA, Zhou S. Re-evaluation of the Antioxidant Activity of Purified Carnosine. Review. 27. Fontaine FR, Dunlop RA, Petersen DR, Burcham PC. Oxidative bioactivation of crotyl alcohol to the toxic endogenous aldehyde crotonaldehyde: association of protein carbonylation with toxicity in mouse hepatocytes. Chem Res Toxicol. 2002;15(8):1051-8
28. Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer's disease. J Neurochem. 2000; 75:436-9.
29. Boldyrev AA, Johnson P, Wei Y, et al. Carnosine and taurine protect rat cerebellar granular cells from free radical damage. Neurosci Lett. 1999;263(2-3):169-72.
30. Burcham PC, Kerr PG, Fontaine F. The antihypertensive hydralazine is an efficient scavenger of acrolein. Redox Rep. 2000;5(1):47-9.
31. Gra. Menéndez, Padrón Pérez, Libre Rodríguez. "Péptido beta amiloide , proteína Tau y enfermedad de Alzheimer". Rev. Cubana Invest. Biomed 2002: 21 (4) : 253-61.
32. Suslina ZA, Federova TN, Maksimova MIu et al. [Antioxidant therapy in ischemic stroke] Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(10):34-8
33. Thorpe SR, Baynes JW Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 1996;9(2):69-77
34. Baynes JW, Torpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48 (1) 1-9
35. Stuerenburg HJ. The roles of carnosine in aging of skeletal muscle and in neuromuscular diseases. Biochemistry (Mosc). 2000 Ju1;65(7):862-5. Review.
36. Gamez Navarro HA. Calcio y enfermedades cardiovascular. Med Crit Venez 2000;15:17-23
37. Bharadwaj LA, Davies GF, Xavier IJ, Ovsenek N. L-carnosine and verapamil inhibit hypoxia-induced expression of hypoxia inducible factor (HIF-1 alpha) in H9c2 cardiomyoblasts. Pharmacol Res. 2002;45(3):175-181. |